MARLET 2.5 MG FILM COATED 30 TABLET -WASFATY
Product Overview
Marlet 2.5 mg Film-Coated Tablets offer a targeted approach to hormone therapy, primarily utilized for the treatment of hormone receptor-positive breast cancer in postmenopausal women. This medication contains Letrozole, a potent aromatase inhibitor that effectively reduces estrogen levels in the body, thereby inhibiting the growth of hormone-sensitive cancer cells.
Developed by Spimaco, Marlet 2.5 mg is a prescription-only drug that is also recognized for its off-label use in certain fertility treatments, always requiring strict medical supervision. Each pack contains 30 oral film-coated tablets, designed for convenient daily administration.
Benefits of Use
- Effective in the adjuvant and extended adjuvant treatment of early hormone receptor-positive breast cancer in postmenopausal women.
- Serves as a first-line treatment for advanced hormone receptor-positive breast cancer in postmenopausal women.
- Can be used for the treatment of advanced breast cancer in women whose disease has progressed following anti-estrogen therapy.
- May aid in ovulation induction as part of fertility treatments under specific medical guidance.
- Helps reduce the risk of cancer recurrence by lowering estrogen levels, a key driver of hormone-sensitive tumors.
How to Use
- Always take Marlet 2.5 mg exactly as prescribed by your doctor.
- The usual dose is one 2.5 mg tablet once daily.
- Swallow the tablet whole with a glass of water.
- Marlet tablets can be taken with or without food.
- It is recommended to take your dose at approximately the same time each day to maintain consistent drug levels.
- Do not stop taking Marlet without consulting your doctor, even if you feel well, as stopping treatment prematurely may affect its effectiveness.
Caution & Warnings
- Marlet 2.5 mg is contraindicated in premenopausal women, pregnant women, and breastfeeding mothers.
- Patients with severe kidney or liver impairment should use this medication with caution and under strict medical supervision.
- Regular monitoring of bone mineral density may be required, as Letrozole can cause a decrease in bone density, increasing the risk of osteoporosis and fractures.
- Common side effects include hot flashes, joint pain, fatigue, nausea, headache, dizziness, and increased sweating. Report any persistent or severe side effects to your doctor.
- Avoid driving or operating machinery if you experience dizziness or tiredness.
- Inform your doctor about all other medications, supplements, and herbal products you are taking to avoid potential drug interactions.
Ingredients
Active ingredient: Letrozole 2.5 mg
Product Details
- Brand: Marlet
- Manufacturer: Spimaco
- Active Ingredient: Letrozole
- Strength: 2.5 mg
- Dosage Form: Film-Coated Tablets
- Package Size: 30 Tablets
- Drug Type: Prescription Medicine
- Gender: Female (primarily for postmenopausal women)
- Administration Route: Oral
| Gtin | 10101100463100OOO |
|---|---|
| Recommended Sale Price | 165.2 |
| Is Wasfaty Product | No |
| Brand | MARLET |
| Ingredient Name | LETROZOLE |
| SFDA Reg. No | 0601244679 |
| IBC | 10101100463100OOO |
| Drug Type | prescription |
| Scientific Name | Letrozole |
| Strength | 2.5 |
| Strength Unit | MG |
| Form | Film-Coated Tablets |
| Admin Route | Oral |
| Size | 30 |
| Size Unit | TABLET |
| Package Types | Pack |
| Package Size | 30 Tablets |
| shelfLife | 24 months |
| Storage conditions | Store below 30°C. Protect from moisture and light. |
| Refrigerator Storage | No |
| Distribute area | Saudi Arabia |




